Details of the Drug Formulaction

General Information of Drug Formulation (ID: F20498)

• Formulation Name: Sulindac 150 mg tablet
• Company: Major Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Sulindac	(DM2QHZU)	Acute myelogenous leukaemia	2A41	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Magnesium stearate	(E00208)	11177	lubricant